Search clinical trials for: To evaluate the effect of advancing Jaw on airway dimension
Total 492754 results
-
Doctor's Directive Strategies Inc.CompletedObstructive Sleep ApneaCanada
-
Spirair, IncRecruitingNasal Airway Obstruction | Nasal Septal DeviationUnited States
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Germany, Belgium, Korea, Republic of, Poland, Taiwan, Israel, New Zealand, Sweden, United Kingdom, Japan, Czechia, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, Brazil, Fran... and more
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Sohag UniversityNot yet recruitingChange of Tempromandibular Joint Function With Supra Glottic Airway Devices
-
NewAmsterdam PharmaMonash UniversityRecruitingAtherosclerotic Cardiovascular DiseaseUnited States, Israel, Italy, Spain, Canada, Czechia, Poland, China, Denmark, Netherlands, Finland, Japan, Australia, Hungary, Germany, Croatia, United Kingdom, Bulgaria, South Africa, Georgia, Jordan, Slovakia, Latvia
-
Hoffmann-La RocheRecruitingSystemic Lupus ErythematosusBrazil, United States, Argentina, United Kingdom, New Zealand, Spain, Italy, Peru, Poland, South Africa, France, Mexico, Russian Federation, Czechia
-
Sun Yat-sen UniversityRecruiting
-
PfizerActive, not recruitingDermatitis, AtopicChina, United States, Spain, Taiwan, Germany, Australia, Canada, Hungary, Korea, Republic of, Poland, Serbia, Bulgaria, Czechia, Japan, Latvia, United Kingdom, Belgium, Israel, Italy, Finland, Mexico, Romania, Slovakia, Argentina, Brazil, Chil... and more
-
Regeneron PharmaceuticalsCompletedAsthmaUnited States, Spain, France, Germany, Poland
-
AmgenCompletedMigraine HeadacheUnited States, Austria, Australia, Czechia, Finland, France, Hungary, Italy, Poland, Portugal, Spain, United Kingdom
-
Shin Poong Pharmaceutical Co. Ltd.CompletedHypertension | Essential HypertensionKorea, Republic of
-
NewAmsterdam PharmaActive, not recruitingDyslipidemias | Hypercholesterolemia | Familial Hypercholesterolemia | Atherosclerotic Cardiovascular Disease | High CholesterolUnited States, Poland, Denmark, Czechia, China, Netherlands, Japan, Georgia
-
Al-Azhar UniversityWorld Health OrganizationActive, not recruitingNasal Airway Obstruction | Maxillary RetrusionEgypt
-
PATHLiverpool School of Tropical Medicine; University of Rwanda; Rwanda Biomedical...Completed
-
HNO-Praxis Alte PostAerin MedicalCompletedNasal Obstruction, BilateralGermany
-
Ensysce BiosciencesCompletedRecreational Drug UseUnited States
-
Bristol-Myers SquibbCompletedPsoriasisUnited States, Spain, Hungary, Australia, Germany, Canada, Czechia, Poland, Puerto Rico, Finland, France, Israel, Italy, New Zealand, Sweden, United Kingdom
-
Damascus UniversityCompletedClass III MalocclusionSyrian Arab Republic
-
Taner OZTURK, DDS, MSCompletedClass III Malocclusion | Hyoid BoneTurkey
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
ECRI bvBayer; Rigshospitalet, Denmark; Cardialysis BVCompletedCardiovascular Diseases | Thrombosis | Aortic Valve Stenosis | Heart Valve Diseases | Ventricular Outflow ObstructionGermany, United States, Denmark, Switzerland, Netherlands, Sweden, Canada
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
Mundipharma Research LimitedCompletedAsthmaUnited Kingdom, Sweden, Australia, New Zealand, Slovakia
-
The University of Hong KongCompleted
-
Maire Mac BrideNational Center for Advancing Translational Sciences (NCATS)TerminatedAtrophic VaginitisUnited States
-
Shanghai Public Health Clinical CenterUnknownTo Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
-
University of Alabama at BirminghamBioHorizons, Inc.CompletedJaw, Edentulous, PartiallyUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
AstraZenecaCompleted
-
Elite Laboratories, IncCompletedWithdrawal SymptomsUnited States
-
University Hospital, AntwerpChiesi Farmaceutici S.p.A.Completed
-
Professor Fernando Figueira Integral Medicine InstituteCompletedHemorrhage | Cleft Palate
-
University of Sao PauloCompletedNon-obstructive Hypertrophic Cardiomyopathy | Obstructive Hypertrophic CardiomyopathyBrazil
-
G. Pohl-Boskamp GmbH & Co. KGUniversitätsklinikum Hamburg-EppendorfCompleted
-
Nivalis Therapeutics, Inc.Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
Emory UniversityNational Institutes of Health (NIH)Completed
-
KU LeuvenChiesi Farmaceutici S.p.A.UnknownEmphysema | COPD | Small Airway DiseaseBelgium
-
Karolinska University HospitalKarolinska InstitutetUnknown
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung DiseaseUnited Kingdom
-
Dojode, Chetan M., MBBS, MSCompletedTennis Elbow | Epicondylitis, Lateral HumeralIndia
-
National Institute of Allergy and Infectious Diseases...Completed
-
GlaxoSmithKlinePPD; Laboratory Corporation of AmericaNot yet recruiting
-
Bostal Drug Delivery Co., LtdNot yet recruiting
-
The First Affiliated Hospital of Henan University...Not yet recruitingEvaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis
-
Koya Medical, Inc.RecruitingLymphedema | Chronic Venous Insufficiency | PhlebolymphedemaUnited States
-
Top Health S.A.P.I DE C.V.CLINICAL RESEARCH PS MEXICONot yet recruiting